What is Precision Labs?
Precision Labs operates as a specialized reference laboratory, delivering high-precision urinalysis services underpinned by Gold Standard LC MS/MS technology. The firm serves a critical role in the healthcare ecosystem, providing essential drug detection and monitoring capabilities to behavioral health facilities, addiction treatment centers, and primary care providers. Beyond mere testing, the organization distinguishes itself through expert clinical consultation, assisting practitioners in the interpretation of complex data to optimize patient treatment plans. This dual focus on technological accuracy and educational outreach in addiction medicine positions Precision Labs as a vital partner for clinicians navigating the complexities of modern medication monitoring and patient care.
How much funding has Precision Labs raised?
Precision Labs has raised a total of $367K across 2 funding rounds:
Debt
$150K
Debt
$217K
Debt (2020): $150K with participation from PPP
Debt (2021): $217K led by PPP
Key Investors in Precision Labs
PPP
Public-Private Partnership
What's next for Precision Labs?
With the successful procurement of this late-stage capital, Precision Labs is well-positioned to accelerate its growth trajectory and expand its diagnostic footprint. The strategic deployment of these funds will likely focus on enhancing laboratory throughput, integrating advanced analytical software, and broadening its reach within the OBGYN and addiction treatment markets. As the company matures, the emphasis will shift toward operational efficiency and the scaling of its proprietary testing methodologies to maintain a competitive edge in the high-stakes diagnostic industry. Future initiatives will likely prioritize the expansion of its clinical consultation services, further cementing its reputation as a leader in evidence-based addiction medicine and diagnostic reliability.
See full Precision Labs company page
